Literature DB >> 6812031

Distribution and metabolism of cyclo (His-Pro): a new member of the neuropeptide family.

C Prasad, M Mori, J F Wilber, W Pierson, J Pegues, A Jayaraman.   

Abstract

Cyclo (His-Pro) is a biologically active cyclic dipeptide derived from thyrotropin-releasing hormone by its limited proteolysis. We have developed a specific radioimmunoassay for this cyclic peptide and shown its presence throughout rat and monkey brains. The normal rat brain concentration of cyclo (His-Pro) ranged from 35-61 pmols/brain. The elution profiles of rat brain cyclo (His-Pro)-like immunoreactivity and synthetic radioactive cyclo (His-Pro) following gel filtration, ion-exchange chromatography, and high pressure liquid chromatography were similar. An analysis of the regional distribution of cyclo (His-Pro) and TRH in rat and monkey brains exhibited no apparent precursor-product relationship. The possible additional factors determining regional differences in the endogenous cyclo (His-Pro) concentrations are discussed. The endogenous levels of brain cyclo (His-Pro) were elevated when rats were made either hypothyroid by surgical thyroidectomy or forced to drink alcohol for six weeks. These studies demonstrate that cyclo (His-Pro) is present throughout the central nervous system in physiologically relevant concentrations which can be modulated by appropriate physiological and pharmacological manipulations. These data in conjunction with earlier reports of multiple biological activities of exogenous cyclo (His-Pro), suggest that endogenous cyclo (His-Pro) is a biologically active peptide and it may play a neurotransmitter or neuromodulator role in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812031     DOI: 10.1016/0196-9781(82)90129-2

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

1.  On the mechanism of fasting-associated elevations in hypothalamic cyclo(His-Pro) content.

Authors:  C Prasad; T Iriuchijima; R M Edwards; J F Wilber; M Mori; D J Rogers
Journal:  Neurochem Res       Date:  1986-03       Impact factor: 3.996

2.  Effect of low intravenous doses of TRH, acid-TRH and cyclo(His-Pro) on cerebral and peripheral blood flows.

Authors:  L O Koskinen
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

3.  Neuropeptides TRH and cyclo(His-Pro) share neuromodulatory, but not stimulatory, action on hypothalamic neurons in vitro: implication for the regulation of feeding.

Authors:  L M Kow; D W Pfaff
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

Review 4.  Is all cyclo(His-Pro) derived from thyrotropin-releasing hormone?

Authors:  C Prasad; A Jayaraman; H J Robertson; J K Rao
Journal:  Neurochem Res       Date:  1987-09       Impact factor: 3.996

5.  Histidyl-proline diketopiperazine (His-Pro DKP) immunoreactivity is present in the glucagon-containing cells of the human fetal pancreas.

Authors:  P Leduque; I M Jackson; A Kervran; S Aratan-Spire; P Czernichow; P M Dubois
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

6.  Characterization and subcellular distribution of specific thyrotropin-releasing hormone binding sites in rat cerebellum.

Authors:  C Prasad; R M Edwards
Journal:  Neurochem Res       Date:  1984-04       Impact factor: 3.996

7.  Developmental changes in the distribution of rat brain pyroglutamate aminopeptidase, a possible determinant of endogenous cyclo(His-Pro) concentrations.

Authors:  C Prasad; M Mori; W Pierson; J F Wilber; R M Ewards
Journal:  Neurochem Res       Date:  1983-03       Impact factor: 3.996

8.  Prebiotic formation of cyclic dipeptides under potentially early Earth conditions.

Authors:  Jianxi Ying; Rongcan Lin; Pengxiang Xu; Yile Wu; Yan Liu; Yufen Zhao
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.